UH President Renu Khator (right) and Principal, Vice-Chancellor and Professor of HWU Richard A. Williams signed the memorandum earlier this month. Photo via UH.edu

The University of Houston and Heriot-Watt University in Scotland signed a memorandum of understanding earlier this month that celebrates an official partnership between the schools in education, research, and innovation for the energy transition.

The universities will particularly focus on hydrogen energy solutions, according to a statement from UH.

"I am thrilled to witness the official celebration of our shared commitment to advancing transformative energy solutions,” Ramanan Krishnamoorti, vice president for energy and innovation at UH, says in a statement. “Through this partnership, we aim to harness our collective expertise to address pressing energy challenges and drive sustainable innovation on a global scale."

UH President Renu Khator and Principal, Vice-Chancellor and Professor of HWU Richard A. Williams signed the memorandum on April 11. Faculty members from UH and HWU then held a two-day technology workshop in Houston where the teams discussed areas of collaboration and future projects.

Through the partnership, the schools aim to offer more opportunities for students and faculty via interdisciplinary research, student exchange programs, joint degree offerings and industry partnerships around the world. HWU, for instance, has five campuses throughout Scotland, the UAE and Malaysia.

“This agreement represents a pivotal milestone in the international development of our global research institutes, forging a new partnership to address the most pressing societal challenges that lie ahead,” Gillian Murray, deputy principal of business and enterprise at HWU who attended the signing, adds in the statement.

Houston has been a hub for notable partnerships focused on the energy transition in recent months.

The Greater Houston Partnership and the Houston Energy Transition Initiative announced last month during CERAWeek that they had signed a memorandum of understanding with Argonne National Laboratory, a federally-funded research and development facility in Illinois owned by the United States Department of Energy and run by UChicago Argonne LLC of the University of Chicago.

The partnership aims to spur the development of commercial-scale energy transition solutions.

------

This article originally ran on EnergyCapital.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”